Subcyclo laser procedure results in patients with glaucoma

Area of Science:

• Ophthalmology
• Medical Technology
• Glaucoma Treatment

Background:

• Glaucoma is a leading cause of irreversible blindness worldwide.
• Elevated intraocular pressure (IOP) is a primary risk factor for glaucoma progression.
• Transscleral cyclophotocoagulation (TSCPC) is an established procedure for managing refractory glaucoma.

Purpose of the Study:

• To evaluate the efficacy and safety of the subliminal transscleral cyclophotocoagulation (subCyclo) laser procedure.
• To analyze the impact of subCyclo on intraocular pressure (IOP) in diverse glaucoma subtypes.
• To assess the complication profile associated with the subCyclo procedure.

Main Methods:

• The study involved 50 eyes from 32 patients with various glaucoma subtypes.
• Subliminal transscleral cyclophotocoagulation (subCyclo) was performed under retrobulbar anesthesia.
• Patients continued antiglaucoma medication and received topical steroids; minimum follow-up was 6 months.

Main Results:

• Mean IOP decreased from 26.27 mmHg preoperatively to 15.9 mmHg one day post-procedure.
• IOP remained significantly reduced at 13.72 mmHg at 7 days and stabilized around 16 mmHg up to 6 months.
• Re-intervention was needed in 9 eyes; minor complications included transient ocular hypertonia and mydriasis.

Conclusions:

• The subCyclo laser procedure demonstrates early success in achieving significant IOP reduction.
• The treatment shows a favorable safety profile with a low incidence of serious complications.
• SubCyclo presents a viable option for managing glaucoma patients requiring IOP control.